FDA Approves Naloxone Nasal Spray to Reverse Opioid Overdose

Posted on: December 21st, 2015 by sobrietyresources

NATIONAL INSTITUTE ON DRUG ABUSE

November 18, 2015

NATIONAL INSTITUTE ON DRUG ABUSE (11/18) – The National Institute on Drug Abuse (NIDA), part of the National Institutes of Health, is pleased to announce that intranasal naloxone –a nasal spray formulation of the medication designed to rapidly reverse opioid overdose – has been approved by the U.S. Food and Drug Administration (FDA). The new technology has an easy-to-use, needle-free design, providing family members, caregivers and first responders with an alternative to injectable naloxone for use during a suspected opioid overdose. The new technology will be marketed by Adapt Pharma Limited, a partner of Lightlake Therapeutics Inc. NIDA and Lightlake, a biopharmaceutical company developing novel treatments for addiction, entered into a partnership in 2013 to apply new technology towards developing a lifesaving intervention for opioid overdose. The product will be marketed under the brand name NARCAN® Nasal Spray. Read more

Copyright 2017. All Rights Reserved.